| Join | Site Map | Contact EMS | Home |
General Information Meeting Agenda Abstracts Exhibits Sponsors Registration Hotel & Travel

Special Interest Groups (SIGs)

Breakfast Meeting Agendas

Sunday, October 19, 2008
DNA Repair Special Interest Group
7:30 AM

Discussion of DNA Repair Pathways as Therapeutic Targets in Cancer Therapy
Speakers: Joann B. Sweasy, Yale University School of Medicine and Mats Ljungman, The University of Michigan

 
Epigenetics Special Interest Group
7:30 AM Discussion SIG Activities, Future Planning
7:50 AM Brief Scientific Presentations (To Be Announced) and Discussion
 
Transgenic & In Vivo Mutagenesis Special Interest Group
7:30 AM

General Introduction
Nominations and Elections for Chair and Secretary TIVM SIG 2008–2009
Circulate Membership List Update
New Business

7:40 AM

P87
Time Course of Chemical-Induced In Vivo Genotoxicity Evaluated Using a Combined Protocol for Micronucleus and Comet Analyses.

Speaker: Cheryl A. Hobbs, Integrated Laboratory Systems, Inc.

8:00 AM

P56
Nuclear and Mitochondrial Mutations in Cancer.
Speaker: Jason H. Bielas, University of Washington

8:20 AM

P41
Validation of Transgenic Rodent Gene Mutation Assays Using DNA Sequence Data.

Speaker: George R. Douglas, Environmental Health Science & Research Bureau, Health Canada

8:40 AM

P112
Detection of Weak Mutagens in Transgenic Rodent Mutation Assays: Challenging the International Workshops on Genotoxicity Testing Protocol Recommendations.

Speaker: Tim M. Singer, Health Canada

 


Monday, October 20, 2008
Germ Cell, Stem Cell, and Human Genetics Special Interest Group (GeSteHuG SIG)
7:30 AM High Levels of Transcription Stimulate Base Substitution Mutations in Yeast
Speaker: Malcolm J. Lippert, Saint Michael's College
7:45 AM Human Recombination Hotspots
Speaker: Norman Arnheim, University of Southern California
8:00 AM DMN Disturbs Sex Differentiation and Induces Transgenerational Damage from Affected Males
Speaker: Patricia Ramos-Morales, Universidad Nacional Autonoma de Mexico
8:15 AM Germline Mutation in Male and Female Mice Exposed to Diesel Exhaust Particles In Utero
Speaker: Lynn Berndt-Weis and Carole L. Yauk, Health Canada
8:30 AM Applications of Massively Parallel Sequencing: To Human Genetics Different Technologies, Different Sweet Spots
Speaker: Steve S. Sommer, City of Hope
 
New Technologies Special Interest Group
New Tools to Detect Mutagenicity/Immunotoxicity
7:30 AM

Breakfast & Discussion on the SIG activities:
Survey
Future activities of the SIG
3–5 elements of the SIG as critical components of the new EMS mission statement
Web site

8:00 AM

Utilizing Kinase Inhibitory Profiles to Predict In Vitro Micronucleus Assay Results
Speaker: Andrew J. Olaharski, Discovery and Investigative Safety, Roche

8:25 AM

Developing Biomarkers of Immunotoxicity
Speaker: Paurene Duramad, Genentech

8:50 AM

Concluding Remarks/Comments

 


Tuesday, October 21, 2008
Molecular Epidemiology Special Interest Group
7:00 AM PIG-A Assay, New Method for Human Biomonitoring
Speaker: Richard J. Albertini, University of Vermont, Burlington
7:25 AM Cytogenetic Biomarkers of Cancer Risk: What Next?
Speaker: Hannu Norppa, Finnish Institute of Occupational Health
7:50 AM The Role of Molecular Epidemiology to Understand the Impact of Global Warming on Human Health
Speaker: Nina T. Holland, University of California, Berkeley
8:15 AM Discussion—Future Activities of SIG
 
Risk Assessment Special Interest Group
7:00 AM Welcome, Introduction, Discussion of the SIG activities
7:15 AM European EMS Genotoxicity and Risk Assessment Discussions—An Update
Speaker: David J. Kirkland, Covance Laboratories Ltd.
7:30 AM EPA Mutagenic Mode of Action—Where it Stands?
Speaker: Rita Schoeny, U.S. EPA
7:45 AM Relevance and Follow-Up of Positive Results in In Vitro Genetic Toxicity Testing—An ILSI/HESI Activity Update
Speaker: Bhaskar Gollapudi, Dow Chemicals
8:00 AM Revising on Definitions of Mutagenicity/Genotoxicity in Risk Assessment—A Discussion
Moderator: Nagu Keshava, U.S. EPA